Now let me get the Q1 2026 earnings call transcript for management commentary, plus recent news and stock price data.# 3M Company (MMM) — Q2 2026 Earnings Preview Report date: Tuesday, July 21, 2026, before market open | Call: 9:00 a.m. ET
MMM shares enter earnings around $159, roughly flat year-to-date but well off the February high near $175 and up meaningfully from the early-May low near $141. The stock has been recovering through June/July as investor sentiment around CEO Bill Brown's operational turnaround has improved.
Sentiment is generally positive, with investors hopeful for improved growth and margins due to management efforts to overhaul the business and portfolio mix, despite a mixed macro landscape. Street consensus going into the print: organic growth of approximately 3.15%, operating margins of approximately 24.65%, and EPS of $2.24 for Q2.
3M's Q1 came in ahead of expectations on orders, margins, earnings and cash, setting up the key debate for Q2:
Management explicitly guided to sequential acceleration: we expect organic growth in the second quarter to be higher than 3%, with all the 3 BGs accelerating. SIBG, which was at 3.2%, obviously going higher than that. TEBG, low single digit. And CBG flat to positive. They also framed the cadence bluntly: we see Q2 being better than Q1. And we see the second half being better than the first half. Any shortfall here — especially in Consumer or Transportation & Electronics — would be a red flag for the full-year algorithm.
A major debate on the Q1 call was whether the order/backlog surge reflected genuine demand or customers front-running 3M's April/May oil-linked price increases. Management's own framing: any pre-buy that's happened will wash out in Q2, but we do see acceleration in the back half on the back of really core operating fundamentals around NPI and commercial excellence. Watch closely whether Q2 organic growth still clears management's 3%+ bar once any pre-buy reverses — this is the single biggest swing factor for how the print is received.
Management guided Q2 operating margin to roughly 24.5%, with between volume and productivity, we'll offset all the last quarter of the tariff year-over-year impact for us, a pickup in stranded costs and investments. On pricing, 3M layered incremental surcharge-like price increases tied to rising oil costs: we have about 45% of our cost of goods is raw materials and about 1/3 of that... is its basis in polychem... What we've seen so far and expect is about $125 million of cost increase there, which are offsetting into pricing. That implies total 2026 price contribution near 1.3 points (80 bps base inflation pass-through + ~50 bps oil-related). Investors should check whether price/cost stayed neutral-to-positive as promised, given 3M was price/cost negative on tariffs a year ago.
3M built a $0.05–$0.15 EPS contingency into full-year guidance for macro/input-cost uncertainty tied to oil prices and volatility (e.g., Middle East-related supply risk). CFO Anurag Maheshwari said the update would come at this report: come July, we will give you an update on where we stand for the full year. Removal or narrowing of the contingency would be read as a confidence signal; retention or expansion would suggest lingering caution.
Legal and environmental liabilities remain a persistent factor in 3M's story and cash flow, even if now mostly non-operating "special items":
None of this is likely to move Q2 headline numbers (these are treated as special items excluded from adjusted EPS), but cash outflows and potential new accruals are a persistent tax on free cash flow and a headline risk given the steady cadence of new PFAS suits.
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Adjusted EPS | $2.14 | $1.88 |
| Adjusted operating margin | 23.8% | 23.5% |
| Adjusted organic sales growth | 1.2% | — |
| Adjusted free cash flow | $541M | $489M |
| Cash & equivalents | $3.7B | $6.3B (Q1'25 end) |
| Shareholder returns | $2.4B ($400M div + $2.0B buyback) | — |
Cash fell from $5.2B to $3.7B in the quarter, primarily reflecting the pace of buybacks and litigation-related payments — worth watching whether that pace of capital return continues alongside the pending ~$1.95B Madison acquisition financing.
The Q2 print is really a credibility test for management's "acceleration through the year" narrative. Consensus (~3.15% organic growth, ~24.65% margin, $2.24 EPS) is roughly in line with what management itself guided to on the Q1 call. The key swing factors are: (1) whether the Q1 order surge was real demand or pre-buying that reverses, (2) whether oil-driven cost inflation was fully offset by price as promised, and (3) whether the Consumer segment's improving POS trend has translated into actual organic growth. A clean beat-and-raise, or explicit removal of the EPS contingency, would reinforce the turnaround thesis; a miss on organic growth — even with margin/EPS in line — would revive concerns that the "acceleration" is more optics (pricing, backlog timing) than durable demand. Legal/PFAS headlines will continue to generate news flow but are unlikely to be the swing factor for the stock reaction this quarter.